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Abstract
Purpose: To determine whether CT texture features can
yield prognostic information in addition to conventional
prognostic factors in stage III non-small cell lung cancer
(NSCLC).
Methods: We conducted a retrospective review of 91 pa-
tients with stage III NSCLC treated with definitive chemora-
diation. All patients received a four-dimensional (4D) CT
simulation, where we utilized the average image (aver-
age-CT) and an expiratory image (T50-CT), and a diagnostic
contrast enhanced CT image (CE-CT). A penalized cox re-
gression model was used for covariate selection and model
development. Models incorporating texture features from
the 3 image types and clinical factors were compared to
models incorporating clinical factors alone for overall sur-
vival (OS), local-regional control (LRC), and freedom from
distant metastases (FFDM). Predictive Kaplan-Meier curves
were generated using leave-one-out cross-validation. Strati-
fication into low-risk and high-risk groups was based on a
patient’s predicted outcome being greater or less than the
median. Reproducibility of texture features was evaluated
using test-retest scans from independent patients. The con-
cordance correlation coefficient (CCC) was used to assess
texture feature reproducibility and classification accuracy
was used to assess reproducibility of texture features within
the context of our models.
Results: Models incorporating both texture and clinical fea-
tures demonstrated a significant improvement in stratifica-
tion compared to models using clinical features alone in
cross-validated Kaplan-Meier curves in terms of OS (p =
0.046), LRC (p = 0.01), and FFDM (p = 0.005). The average
CCC was 0.89, 0.91, and 0.67 for texture features extracted
from the average-CT, T50-CT, and CE-CT, respectively. In-
corporating reproducibility uncertainties within our model
yielded 80.4 (SD = 3.7), 78.3 (SD = 4.0), and 78.8 (SD = 3.9)
percent classification accuracy for OS, LRC, and FFDM, re-
spectively.
Conclusion: Pretreatment tumor texture may provide prog-
nostic information in additional to routinely obtained clini-
cal features. Reproducibility of CE-CT appears inferior to
average-CT and T50-CT; however model classification accu-
racy rates of ~80% were still achieved.
--------------------------------------------
Key Results To analyze the influence of texture repro-
ducibility on our models, we determined the mean and
standard deviation of the differences between each
texture feature acquired on test-retest images. We
randomly sampled a normal distribution with the
aforementioned mean and standard deviation for each
texture feature and added this uncertainty to the
matching feature in our 91 patients. A comparison of
the original model versus a model incorporating fea-
ture reproducibility is shown in Figure 2. Patients that
remained in the same risk category (red and green) di-
vided by the total number of patients were used to
calculate classification accuracy.
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FIG. 1: Cross-validated Kaplan-Meier Curves for Models With and Without Texture Features.
FIG. 2: Impact of Texture Feature Reproducibility on FFDM Estimates
